Acetylation of the Pro-Apoptotic Factor, p53 in the Hippocampus following Cerebral Ischemia and Modulation by Estrogen
MetadataShow full item record
AbstractBackground: Recent studies demonstrate that acetylation of the transcription factor, p53 on lysine373 leads to its enhanced stabilization/activity and increased susceptibility of cells to stress. However, it is not known whether acetylation of p53 is altered in the hippocampus following global cerebral ischemia (GCI) or is regulated by the hormone, 17b-estradiol (17b2E2), and thus, this study examined these issues.
Methodology/Principal Findings: The study revealed that Acetyl p53-Lysine373 levels were markedly increased in the hippocampal CA1 region after GCI at 3 h, 6 h and 24 h after reperfusion, an effect strongly attenuated by 17b2E2. 17b2E2 also enhanced interaction of p53 with the ubiquitin ligase, Mdm2, increased ubiquitination of p53, and induced its downregulation, as well as attenuated elevation of the p53 transcriptional target, Puma. We also observed enhanced acetylation of p53 at a different lysine (Lys382) at 3 h after reperfusion, and 17b2E2 also markedly attenuated this effect. Furthermore, administration of an inhibitor of CBP/p300 acetyltransferase, which acetylates p53, was strongly neuroprotective of the CA1 region following GCI. In long-term estrogen deprived (LTED) animals, the ability of 17b2E2 to attenuate p53 acetylation was lost, and intriguingly, Acetyl p53-Lysine373 levels were markedly elevated in sham (non-ischemic) LTED animals. Finally, intracerebroventricular injections of Gp91ds-Tat, a specific NADPH oxidase (NOX2) inhibitor, but not the scrambled tat peptide control (Sc-Tat), attenuated acetylation of p53 and reduced levels of Puma following GCI.
Conclusions/Significance: The studies demonstrate that p53 undergoes enhanced acetylation in the hippocampal CA1 region following global cerebral ischemia, and that the neuroprotective agent, 17b2E2, markedly attenuates the ischemiainduced p53 acetylation. Furthermore, following LTED, the suppressive effect of 17b2E2 on p53 acetylation is lost, and p53 acetylation increases in the hippocampus, which may explain previous reports of increased sensitivity of the hippocampus to ischemic stress following LTED.
CitationPLoS One. 2011 Oct 26; 6(10):e27039
- Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.
- Authors: Yang LC, Zhang QG, Zhou CF, Yang F, Zhang YD, Wang RM, Brann DW
- Issue date: 2010 May 7
- Downregulation of G‑protein‑coupled receptor 30 in the hippocampus attenuates the neuroprotection of estrogen in the critical period hypothesis.
- Authors: Wu Y, Feng D, Lin J, Qu Y, He S, Wang Y, Gao G, Zhao T
- Issue date: 2018 Apr
- Attenuation of mitochondrial and nuclear p38α signaling: a novel mechanism of estrogen neuroprotection in cerebral ischemia.
- Authors: Han D, Scott EL, Dong Y, Raz L, Wang R, Zhang Q
- Issue date: 2015 Jan 15
- C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection.
- Authors: Zhang QG, Han D, Wang RM, Dong Y, Yang F, Vadlamudi RK, Brann DW
- Issue date: 2011 Aug 30
- Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus.
- Authors: Zhang QG, Wang R, Tang H, Dong Y, Chan A, Sareddy GR, Vadlamudi RK, Brann DW
- Issue date: 2014 May 25